BE853810A - Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu - Google Patents

Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu

Info

Publication number
BE853810A
BE853810A BE176892A BE176892A BE853810A BE 853810 A BE853810 A BE 853810A BE 176892 A BE176892 A BE 176892A BE 176892 A BE176892 A BE 176892A BE 853810 A BE853810 A BE 853810A
Authority
BE
Belgium
Prior art keywords
vaccine
virus
preparing
procedure
equine rhinopneumonia
Prior art date
Application number
BE176892A
Other languages
English (en)
Original Assignee
Philips Roxane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Roxane filed Critical Philips Roxane
Publication of BE853810A publication Critical patent/BE853810A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27Equine rhinopneumonitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761Methods of inactivation or attenuation
    • C12N2710/16764Methods of inactivation or attenuation by serial passage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/82Viral vaccine for equine species, e.g. horses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE176892A 1976-04-23 1977-04-21 Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu BE853810A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/679,840 US4110433A (en) 1976-04-23 1976-04-23 Equine rhinopneumonitis virus

Publications (1)

Publication Number Publication Date
BE853810A true BE853810A (fr) 1977-10-21

Family

ID=24728588

Family Applications (1)

Application Number Title Priority Date Filing Date
BE176892A BE853810A (fr) 1976-04-23 1977-04-21 Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu

Country Status (14)

Country Link
US (1) US4110433A (fr)
AU (1) AU2454077A (fr)
BE (1) BE853810A (fr)
DD (1) DD131762A5 (fr)
DE (1) DE2717919A1 (fr)
ES (1) ES458113A1 (fr)
FR (1) FR2348704A1 (fr)
GB (1) GB1570732A (fr)
LU (1) LU77166A1 (fr)
NL (1) NL7704239A (fr)
NZ (1) NZ183907A (fr)
PL (1) PL197579A1 (fr)
SE (1) SE7704514L (fr)
SU (1) SU700069A3 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175
US4636469A (en) * 1982-04-07 1987-01-13 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Isolation of hepatitis A virus strain HM-175
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
ES2144400T3 (es) * 1990-08-01 2000-06-16 Res Corp Technologies Inc Gen que codifica la gliproteina d del virus del herpes equino de tipo 1, su producto genico, anticuerpos y su utilizacion.
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
CA2243730C (fr) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Vaccin contre streptococcus equi
RU2252253C2 (ru) * 1999-09-10 2005-05-20 Акцо Нобель Н.В. Температурочувствительный штамм вируса аборта лошадей ehv-1, фармацевтическая композиция, вакцина и способ иммунизации животного
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
BRPI0709282B8 (pt) 2006-03-29 2021-05-25 Merial Ltd vacina contra estreptococos
CN114214289A (zh) * 2021-12-24 2022-03-22 山东省农业科学院畜牧兽医研究所 一株马冠状病毒ECoV464693及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1692043C3 (de) * 1968-03-06 1979-04-12 Behringwerke Ag, 3550 Marburg Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
GB1570732A (en) 1980-07-09
DD131762A5 (de) 1978-07-19
LU77166A1 (fr) 1977-08-12
SU700069A3 (ru) 1979-11-25
AU2454077A (en) 1978-10-26
NL7704239A (nl) 1977-10-25
US4110433A (en) 1978-08-29
NZ183907A (en) 1979-10-25
SE7704514L (sv) 1977-10-24
DE2717919A1 (de) 1977-11-03
PL197579A1 (pl) 1978-09-25
ES458113A1 (es) 1978-03-16
FR2348704A1 (fr) 1977-11-18

Similar Documents

Publication Publication Date Title
IT8022284A0 (it) N-aril-ossazolidinoni e -pirrolidinoni, e procedimenti per la loro preparazione.
IT7820811A0 (it) Fenossi-benzil-ossicarbonil-derivati sostituiti, procedimento per laloro preparazione e loro impiegocome insetticidi e come acaricidi.
BE853810A (fr) Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
IT7820264A0 (it) Oligopeptidi trifluorometilati, procedimento per la loro preparazione e loro applicazione terapeutica.
IT8023392A0 (it) N-propionilsarcosinanilidi, procedimento per la loro preparazione e prodotti medicinali a base di queste sostanze.
IT1207271B (it) Amminoglicosidi, procedimento per la loro preparazione e loro impiego.
IT7926898A0 (it) Procedimento per preparare 1,2,3-tiadiazol-5-il-uree.
NL174345C (nl) Zuur alkalicitraat, werkwijze ter bereiding daarvan en therapeutisch preparaat.
ES523243A0 (es) "procedimiento para preparar derivados de 1,4-dihidropiridina".
IT1146228B (it) Procedimento per preparare 2,6-dialchil-n-alcossimetil-2-cloro-acetanilidi e prodotto ottenuto
AR225920A1 (es) Aldehido-eteres alifaticos,procedimiento para su preparacion y procedimiento para producir butirolactona,butano-1-diol y tetrahidrofurano a partir de los mismos
IT8320023A0 (it) Carbacicline, procedimento per laloro preparazione e loro impiegocome medicinali.
LU79503A1 (fr) Procede de preparation d'un vaccin syncytial du virus respiratoire
IT7829237A0 (it) Procedimento di preparazione distilbeni 4,4'-diossi-sostituiti.
IT7829638A0 (it) 2,4-diammino-5-benzil-pirimidine eprocedimento per la loro preparazione.
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines
MX5355E (es) Procedimiento para la preparacion del hemicetal 3 a alfa-h-4-alfa(3'-propanol)-7-a beta-metilhexahidro-1,5-indandiona
NO812115L (no) Fortilsetning, og fremgangsmaate for fremstilling derav.
ES489469A0 (es) Un procedimiento para la preparacion de 1, 1'-bifenil-2-il- alquilamina.
AR211237A1 (es) Un procedimiento de preparacion de la n-(1'-alilpirrolidinil-2'-mentil)2-metoxi-4,5-azimidobenzamida
IT1099797B (it) 1. 4-idro-firidazine 1-n-sostituite, procedimento per la loro preparazione e loro impiego come prodoiti medicinali
IT7821683A0 (it) Esteri oppure esteri amidi trifluorometil-solfonil-fenil-tiono (tiol) fosforici, procedimento per la loro preparazione e loro impiego come insetticidi e come acaricidi.
USD236248S (en) sntble
NL7802084A (nl) Triazolo-tieno-diazepien-1-onen, werkwijze ter bereiding daarvan en geneesmiddel.